Growth Metrics

Teladoc Health (TDOC) Cash from Investing Activities (2016 - 2025)

Teladoc Health's Cash from Investing Activities history spans 12 years, with the latest figure at -$34.3 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 15.77% year-over-year to -$34.3 million; the TTM value through Dec 2025 reached -$266.0 million, down 114.43%, while the annual FY2025 figure was -$266.0 million, 114.43% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$34.3 million at Teladoc Health, up from -$48.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$2.2 million in Q2 2021 and bottomed at -$123.3 million in Q1 2025.
  • The 5-year median for Cash from Investing Activities is -$36.0 million (2023), against an average of -$39.4 million.
  • The largest annual shift saw Cash from Investing Activities soared 95.15% in 2021 before it tumbled 1968.13% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at -$20.1 million in 2021, then crashed by 168.45% to -$53.9 million in 2022, then soared by 32.26% to -$36.5 million in 2023, then increased by 18.8% to -$29.6 million in 2024, then decreased by 15.77% to -$34.3 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Cash from Investing Activities are -$34.3 million (Q4 2025), -$48.7 million (Q3 2025), and -$59.7 million (Q2 2025).